Hiroyoshi Doihara
   Department   Kawasaki Medical School  Kawasaki Medical School, Department of General Surgery,
   Position   Professor with Special Assignment
Article types 原著
Language English
Peer review Peer reviewed
Title Influences of preoperative metformin on immunological factors in early breast cancer.
Journal Formal name：Cancer chemotherapy and pharmacology
Abbreviation：Cancer Chemother Pharmacol
ISSN code：14320843/03445704
Domestic / ForeginForegin
Volume, Issue, Page 86(1),pp.55-63
Author and coauthor Tsukioki Takahiro, Shien Tadahiko, Tanaka Takehiro, Suzuki Yoko, Kajihara Yukiko, Hatono Minami, Kawada Kengo, Kochi Mariko, Iwamoto Takayuki, Ikeda Hirokuni, Taira Naruto, Doihara Hiroyoshi, Toyooka Shinichi
Publication date 2020/07
Summary PURPOSE:Metformin has been suggested to possibly reduce cancer risk. However, the mechanism underlying the positive effects of metformin on cancer treatment remains unclear. We conducted a prospective study to evaluate the effects of preoperative metformin in patients with early breast cancer.METHOD:We evaluated the effects on immunological factors (TILs, CD4 + , CD8 + , PD-L1, IFNγ and IL-2) by comparing core needle biopsies (CNB) obtained before metformin treatment with surgical specimens. Seventeen patients were enrolled in this prospective study from January to December 2016. We also analyzed 59 patients undergoing surgery during the same period to reveal the correlation of immune factors between CNB and surgical specimen.RESULT:There was a moderate correlation between CNB and surgical specimens on TILs and CD8 + lymphocyte. (TILs Rs = 0.63, CD4 + Rs = 0.224, CD8 + Rs = 0.42) In the metformin group, TILs increases were confirmed in five (29%) patients, while a decrease was confirmed in two (12%). The expressions of CD4 + and CD8 + by TILs were increased in 41% and 18% of surgical specimens, respectively. However, TILs number (p = 0.0554), CD4+ (p = 0.0613) and CD8 + (p = 0.0646) expressions did not significantly increased. Furthermore, IFNγ expression appeared to be increased in response to metformin (p = 0.08).CONCLUSION:Preoperative metformin tends to increase TILs, as well as the numbers of CD4 and CD8 positive lymphocytes, and IFNγ levels. Metformin might improve immune function and have a possibility of chemo-sensitivity and thereby increase the effectiveness of immunotherapy, based on the results of this preliminary study.
DOI 10.1007/s00280-020-04092-2
PMID 32533334